DNA cross-linking agent — Drug Target

All drugs that target DNA cross-linking agent — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Alkylating agent / Antimetabolite

Phase 3 pipeline (1)

• MMC in Trabeculectomy · Pro Top & Mediking Company Limited · Alkylating agent / Antimetabolite · Ophthalmology
  Mitomycin C (MMC) is an alkylating agent that inhibits fibroblast proliferation and collagen synthesis to prevent scarring during trabeculectomy surgery.